文献速递功能神经外科

立体定向放射外科治疗失败后复发特发性三叉神经痛的长期疼痛结局:首次微血管减压术与重复立体定向放射外科的前瞻性比较

Long-term pain outcomes for recurrent idiopathic trigeminal neuralgia after stereotactic radiosurgery: a prospective comparison of first-time microvascular decompression and repeat stereotactic radiosurgery.
PubMed 文献 · J Neurosurg · 2018-10-26

该研究基于前瞻性收集的数据库,比较了立体定向放射外科(SRS)治疗失败后复发特发性三叉神经痛患者接受首次微血管减压术(MVD)与重复SRS的疼痛结局。结果显示MVD组末次随访时80%获得良好结局,而重复SRS组为33.3%(p<0.05);多因素Cox分析显示MVD与良好结局显著相关(HR 0.12,95%CI 0.02-0.60,p<0.01)。作者结论认为MVD后良好结局持续时间长于重复SRS,但两种方式均安全有效。

要点

  • SRS失败后行MVD的患者末次随访良好结局比例(80%)高于重复SRS(33.3%)(p<0.05)。
  • 1年和5年良好结局比例:MVD组分别为86%和75%,重复SRS组分别为73%和27%(p<0.05)。
  • 多因素Cox分析显示MVD与良好结局显著相关(HR 0.12,95%CI 0.02-0.60,p<0.01)。

核心结论

  • SRS失败后接受MVD的患者较接受重复SRS者获得更长的良好结局持续时间;但两种方式均安全有效。
  • 重复SRS后出现感觉改变可预测良好的疼痛结局。

研究设计与样本

  • 研究回顾了1997年至2014年加州大学旧金山分校(UCSF)前瞻性收集的三叉神经痛手术患者数据库,聚焦术前临床特征、手术特征和术后结局。
  • 纳入典型1型特发性三叉神经痛且随访≥1年的患者;168例以SRS为首选手术,其中90例有残留或复发性疼痛,30例在UCSF接受第二次手术且随访≥1年(15例首次MVD,15例重复SRS)。

主要发现

  • MVD组患者较重复SRS组年轻,且更可能在初次SRS中接受≥80 Gy剂量。
  • MVD组平均随访44.9±33.6个月,SRS组平均随访48.3±45.3个月;所有患者随访期间均曾达到无药物完全无痛。
  • 末次随访时,MVD组80%和SRS组33.3%的患者获得良好结局(巴罗神经学研究所疼痛强度评分I-IIIa)(p<0.05)。
  • 1年和5年良好结局比例:MVD组分别为86%和75%,SRS组分别为73%和27%(p<0.05)。
  • 多因素Cox比例风险分析显示,行MVD与良好结局显著相关(HR 0.12,95%CI 0.02-0.60,p<0.01);MVD组内无显著预测因素,而重复SRS后出现感觉改变与疼痛缓解相关(p<0.01)。

关键数值与推荐

  • 良好结局定义为巴罗神经学研究所疼痛强度评分I-IIIa。
  • 末次随访良好结局:MVD组80% vs SRS组33.3%(p<0.05)。
  • 1年良好结局:MVD组86% vs SRS组73%;5年良好结局:MVD组75% vs SRS组27%(p<0.05)。
  • 多因素Cox分析:MVD的HR 0.12(95%CI 0.02-0.60,p<0.01)。

临床怎么用

  • SRS失败后复发特发性三叉神经痛患者,MVD与重复SRS均可选择,两者均安全有效;MVD与更长的良好结局持续时间相关。
  • 重复SRS后出现感觉改变可预测良好的疼痛结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Microvascular decompression (MVD) and stereotactic radiosurgery (SRS) are common surgical treatments for trigeminal neuralgia (TN). Many patients who receive SRS have pain recurrence; the ideal second intervention is unknown. The authors directly compared pain outcomes after MVD and repeat SRS in a population of patients in whom SRS failed as their first-line procedure for TN, and they identified predictors of pain control. METHODS: The authors reviewed a prospectively collected database of patients undergoing surgery for TN between 1997 and 2014 at the University of California, San Francisco (UCSF). Standardized data collection focused on preoperative clinical characteristics, surgical characteristics, and postoperative outcomes. Patients with typical type 1, idiopathic TN with ≥ 1 year of follow-up were included. RESULTS: In total, 168 patients underwent SRS as their first procedure. Of these patients, 90 had residual or recurrent pain. Thirty of these patients underwent a second procedure at UCSF and had ≥ 1 year of follow-up; 15 underwent first-time MVD and 15 underwent repeat SRS. Patients undergoing MVD were younger than those receiving repeat SRS and were more likely to receive ≥ 80 Gy during the initial SRS. The average follow-up was 44.9 ± 33.6 months for MVD and 48.3 ± 45.3 months for SRS. All patients achieved complete pain freedom without medication at some point during their follow-up. At last follow-up, 80% of MVD-treated patients and 33.3% of SRS-treated patients had a favorable outcome, defined as Barrow Neurological Institute Pain Intensity scores of I-IIIa (p < 0.05). Percentages of patients with favorable outcome at 1 and 5 years were 86% and 75% for the MVD cohort and 73% and 27% for the SRS cohort, respectively (p < 0.05). Multivariate Cox proportional hazards analysis demonstrated that performing MVD was statistically significantly associated with favorable outcome (HR 0.12, 95% CI 0.02-0.60, p < 0.01). There were no statistically significant predictors of favorable outcome in the MVD cohort; however, the presence of sensory changes after repeat SRS was associated with pain relief (p < 0.01). CONCLUSIONS: Patients who received MVD after failed SRS had a longer duration of favorable outcome compared to those who received repeat SRS; however, both modalities are safe and effective. The presence of post-SRS sensory changes was predictive of a favorable pain outcome in the SRS cohort.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Raygor KP, Wang DD, Ward MM, et al. Long-term pain outcomes for recurrent idiopathic trigeminal neuralgia after stereotactic radiosurgery: a prospective comparison of first-time microvascular decompression and repeat stereotactic radiosurgery. J Neurosurg. 2018. PMID: 30485183. doi:10.3171/2018.5.JNS172243

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。